Dali Pharmaceuticalco.,Ltd

SSE:603963.SS

1.18 (CNY) • At close February 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Revenue 87.27132.344171.493213.583294.325401.483272.739275.765266.965338.686297.65285.268
Cost of Revenue 50.97357.78645.94357.06673.21679.43287.752146.946143.173172.854141.757127.582
Gross Profit 36.29774.558125.55156.518221.109322.051184.987128.818123.792165.833155.893157.686
Gross Profit Ratio 0.4160.5630.7320.7330.7510.8020.6780.4670.4640.490.5240.553
Reseach & Development Expenses 0.840.9271.4412.8292.232.2392.8683.9763.1082.4255.5012.86
General & Administrative Expenses 5.2325.05119.8089.447.51116.46410.8188.8477.3195.4419.86216.715
Selling & Marketing Expenses 39.77673.686100.791128.532184.213270.91107.17623.37222.1721.52521.87326.84
SG&A 45.00878.736120.599137.973191.725287.374117.99532.21929.4926.96541.73543.555
Other Expenses 3.59817.29116.74117.34816.7670.9976.5920.655-0.275-0.0544.0590.704
Operating Expenses 53.33296.955138.781158.15210.722312.08136.26956.07951.09948.11744.58147.323
Operating Income -17.035-22.397-9.33-2.36215.95511.62245.74372.40173.395118.009111.816110.441
Operating Income Ratio -0.195-0.169-0.054-0.0110.0540.0290.1680.2630.2750.3480.3760.387
Total Other Income Expenses Net -0.3330.169-1.787-1.8771.1680.9976.5920.649-0.275-0.361-3.8060.639
Income Before Tax -17.368-16.998-41.5923.77617.12312.61952.33573.04973.12117.648108.01111.085
Income Before Tax Ratio -0.199-0.128-0.2430.0180.0580.0310.1920.2650.2740.3470.3630.389
Income Tax Expense 2.6630.7040.2990.5443.6181.9187.88310.88410.82817.57815.97816.491
Net Income -20.031-17.702-41.8913.23213.50510.744.45262.16662.293100.0792.03294.594
Net Income Ratio -0.23-0.134-0.2440.0150.0460.0270.1630.2250.2330.2950.3090.332
EPS -0.09-0.081-0.190.0150.0620.0460.30.380.460.910.840.86
EPS Diluted -0.09-0.081-0.190.0150.0620.0460.30.380.460.910.840.86
EBITDA 0.361-11.7-23.78714.30222.51731.33173.2276.65390.106135.287119.506110.362
EBITDA Ratio 0.004-0.088-0.1390.0670.0770.0780.2680.2780.3380.3990.4010.387